A prospective, cross-sectional study of anaemia and peripheral iron status in antiretroviral naïve, HIV-1 infected children in Cape Town, South Africa.

PubWeight™: 1.32‹?› | Rank: Top 10%

🔗 View Article (PMC 65689)

Published in BMC Infect Dis on February 11, 2002

Authors

Brian S Eley1, Alan A Sive, Margaret Shuttleworth, Gregory D Hussey

Author Affiliations

1: School of Child and Adolescent Health, University of Cape Town and Red Cross Children's Hospital, Private Bag, Rondebosch, 7700, South Africa. beley@ich.uct.ac.za

Articles citing this

Anemia and growth failure among HIV-infected children in India: a retrospective analysis. BMC Pediatr (2009) 1.44

The prevalence and etiology of anemia among HIV-infected children in India. Eur J Pediatr (2011) 1.06

Anaemia in HIV-infected children: severity, types and effect on response to HAART. BMC Pediatr (2012) 0.97

Anaemia and zidovudine-containing antiretroviral therapy in paediatric antiretroviral programmes in the IeDEA Paediatric West African Database to evaluate AIDS. J Int AIDS Soc (2013) 0.97

Anemia of inflammation is related to cognitive impairment among children in Leyte, the Philippines. PLoS Negl Trop Dis (2009) 0.96

Growth patterns and anaemia status of HIV-infected children living in an institutional facility in India. Trop Med Int Health (2012) 0.92

Anaemia among clinically well under-fives attending a community health centre in Venda, Limpopo Province. S Afr Med J (2010) 0.86

Predictors and consequences of anaemia among antiretroviral-naïve HIV-infected and HIV-uninfected children in Tanzania. Public Health Nutr (2009) 0.85

Prevalence and factors associated with severe anaemia amongst under-five children hospitalized at Bugando Medical Centre, Mwanza, Tanzania. BMC Hematol (2015) 0.85

Undernutrition and anaemia among HAART-naïve HIV infected children in Ile-Ife, Nigeria: a case-controlled, hospital based study. Pan Afr Med J (2014) 0.84

Prevalence of anemia and underlying iron status in naive antiretroviral therapy HIV-infected children with moderate immune suppression. AIDS Res Hum Retroviruses (2012) 0.83

Factors associated with conversion of long-term non-progressors to progressors: a prospective study of HIV perinatally infected paediatric survivors. Indian J Med Res (2013) 0.83

HIV-associated anemia after 96 weeks on therapy: determinants across age ranges in Uganda and Zimbabwe. AIDS Res Hum Retroviruses (2014) 0.81

Impact of highly active antiretroviral therapy on hematological indices among HIV-1 infected children at Kenyatta National Hospital-Kenya: retrospective study. AIDS Res Ther (2015) 0.81

Chest radiographic pulmonary changes reflecting extrapulmonary involvement in paediatric HIV disease. Pediatr Radiol (2009) 0.78

Anemia, diet and therapeutic iron among children living with HIV: a prospective cohort study. BMC Pediatr (2015) 0.76

Prevalence and associated risk factors of anemia among HIV infected children attending Gondar university hospital, Northwest Ethiopia: a cross sectional study. BMC Hematol (2015) 0.76

[Study of anemia in HIV positive children naive to antiretroviral treatment in Lubumbashi, Democratic Republic of Congo]. Pan Afr Med J (2014) 0.75

Prevalence of anemia and nutritional status among HIV-positive children receiving antiretroviral therapy in Harar, eastern Ethiopa. HIV AIDS (Auckl) (2015) 0.75

Magnitude of cytopenias among HIV-infected children in Bahir Dar, northwest Ethiopia: a comparison of HAART-naïve and HAART-experienced children. HIV AIDS (Auckl) (2017) 0.75

Articles cited by this

Prognostic factors and survival in children with perinatal HIV-1 infection. The Italian Register for HIV Infections in Children. Lancet (1992) 3.52

Epidemiology of anemia in human immunodeficiency virus (HIV)-infected persons: results from the multistate adult and adolescent spectrum of HIV disease surveillance project. Blood (1998) 3.32

Hematologic complications of human immunodeficiency virus infection and the acquired immunodeficiency syndrome. Med Clin North Am (1997) 1.52

Development of a prognosis-based clinical staging system for infants infected with human immunodeficiency virus. J Pediatr (1996) 1.47

Structure, function and clinical significance of transferrin receptors. Clin Chem Lab Med (1999) 1.28

Hematologic aspects of human immunodeficiency virus infection: laboratory and clinical considerations. Am J Hematol (1988) 1.26

1994 revised guidelines for the performance of CD4+ T-cell determinations in persons with human immunodeficiency virus (HIV) infections. Centers for Disease Control and Prevention. MMWR Recomm Rep (1994) 1.09

Anaemia and iron deficiency disease in children. Br Med Bull (1999) 1.08

Defining optimal body iron. Proc Nutr Soc (1999) 1.06

Iron deficiency in children: detection and prevention. Br J Haematol (1999) 1.00

Anthropometric, vitamin A, iron and immunisation coverage status in children aged 6-71 months in South Africa, 1994. South African Vitamin A Consultative Group (SAVACG). S Afr Med J (1996) 0.89

Iron deficiency and intestinal malabsorption in HIV disease. J Pediatr Gastroenterol Nutr (1996) 0.88

Guidelines for the care of children and adolescents with HIV infection. Hematologic manifestations in HIV-infected children. J Pediatr (1991) 0.87

Iron and infection in the tropics: paediatric clinical correlates. Ann Trop Paediatr (1998) 0.83

Serum immunoreactive erythropoietin levels and associated factors amongst HIV-infected children. AIDS (1998) 0.83

Articles by these authors

Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: a randomised, placebo-controlled phase 2b trial. Lancet (2013) 8.18

Distinct, specific IL-17- and IL-22-producing CD4+ T cell subsets contribute to the human anti-mycobacterial immune response. J Immunol (2008) 3.19

Novel application of a whole blood intracellular cytokine detection assay to quantitate specific T-cell frequency in field studies. J Immunol Methods (2004) 2.50

Predictive value of recent QuantiFERON conversion for tuberculosis disease in adolescents. Am J Respir Crit Care Med (2012) 2.32

Bacillus Calmette-Guérin vaccination of human newborns induces T cells with complex cytokine and phenotypic profiles. J Immunol (2008) 2.27

Modified vaccinia Ankara-expressing Ag85A, a novel tuberculosis vaccine, is safe in adolescents and children, and induces polyfunctional CD4+ T cells. Eur J Immunol (2010) 2.25

Dose-finding study of the novel tuberculosis vaccine, MVA85A, in healthy BCG-vaccinated infants. J Infect Dis (2011) 2.24

Individual and contextual factors associated with low childhood immunisation coverage in sub-Saharan Africa: a multilevel analysis. PLoS One (2012) 2.09

Safety and immunogenicity of a new tuberculosis vaccine, MVA85A, in healthy adults in South Africa. J Infect Dis (2008) 2.05

The novel tuberculosis vaccine, AERAS-402, induces robust and polyfunctional CD4+ and CD8+ T cells in adults. Am J Respir Crit Care Med (2010) 2.03

Culture-confirmed childhood tuberculosis in Cape Town, South Africa: a review of 596 cases. BMC Infect Dis (2007) 1.72

Bacillus Calmette-Guérin (BCG) vaccine-induced complications in children treated with highly active antiretroviral therapy. Int J Infect Dis (2008) 1.66

The effect of bacille Calmette-Guérin vaccine strain and route of administration on induced immune responses in vaccinated infants. J Infect Dis (2006) 1.64

Mobile phone text messaging for promoting adherence to anti-tuberculosis treatment: a systematic review. BMC Infect Dis (2013) 1.57

Delaying BCG vaccination from birth to 10 weeks of age may result in an enhanced memory CD4 T cell response. Vaccine (2009) 1.45

The tuberculin skin test versus QuantiFERON TB Gold® in predicting tuberculosis disease in an adolescent cohort study in South Africa. PLoS One (2011) 1.42

Bacillus Calmette Guerin vaccination of human newborns induces a specific, functional CD8+ T cell response. J Immunol (2006) 1.40

Strengthening the expanded programme on immunization in Africa: looking beyond 2015. PLoS Med (2013) 1.32

Induction and regulation of T-cell immunity by the novel tuberculosis vaccine M72/AS01 in South African adults. Am J Respir Crit Care Med (2013) 1.31

Isoniazid plasma concentrations in a cohort of South African children with tuberculosis: implications for international pediatric dosing guidelines. Clin Infect Dis (2009) 1.28

Advances in childhood immunisation in South Africa: where to now? Programme managers' views and evidence from systematic reviews. BMC Public Health (2012) 1.20

Rifampin pharmacokinetics in children, with and without human immunodeficiency virus infection, hospitalized for the management of severe forms of tuberculosis. BMC Med (2009) 1.14

HIV-1 infection in infants severely impairs the immune response induced by Bacille Calmette-Guérin vaccine. J Infect Dis (2009) 1.12

'Communicate to vaccinate' (COMMVAC). building evidence for improving communication about childhood vaccinations in low- and middle-income countries: protocol for a programme of research. Implement Sci (2011) 1.12

A phase IIa trial of the new tuberculosis vaccine, MVA85A, in HIV- and/or Mycobacterium tuberculosis-infected adults. Am J Respir Crit Care Med (2012) 1.09

Higher human CD4 T cell response to novel Mycobacterium tuberculosis latency associated antigens Rv2660 and Rv2659 in latent infection compared with tuberculosis disease. Vaccine (2010) 1.03

Growth and micronutrient disturbances in stable, HIV-infected children in Cape Town. Ann Trop Paediatr (2002) 1.01

Clinical presentation of rheumatic fever in an endemic area. Arch Dis Child (2009) 0.99

The impact of a change in bacille Calmette-Guérin vaccine policy on tuberculosis incidence in children in Cape Town, South Africa. Pediatr Infect Dis J (2006) 0.99

Paediatric anticoagulation guidelines. S Afr Med J (2012) 0.95

Progressive multifocal leukoencephalopathy after initiation of highly active antiretroviral therapy in a child with advanced human immunodeficiency virus infection: a case of immune reconstitution inflammatory syndrome. Pediatr Infect Dis J (2004) 0.94

A bibliometric analysis of childhood immunization research productivity in Africa since the onset of the Expanded Program on Immunization in 1974. BMC Med (2013) 0.94

Making BCG vaccination programmes safer in the HIV era. Lancet (2008) 0.90

Mobile phone text messaging for promoting adherence to anti-tuberculosis treatment: a systematic review protocol. Syst Rev (2013) 0.89

Review of rotavirus studies in Africa: 1976-2006. J Infect Dis (2010) 0.89

Understanding interventions for improving routine immunization coverage in children in low- and middle-income countries: a systematic review protocol. Syst Rev (2013) 0.89

Determining causes of mortality in children enrolled in a vaccine field trial in a rural area in the Western Cape Province of South Africa. J Paediatr Child Health (2007) 0.88

The use of supplementary immunisation activities to improve uptake of current and future vaccines in low-income and middle-income countries: a systematic review protocol. BMJ Open (2014) 0.88

Incidence and Diagnosis of Pertussis in South African Children Hospitalized With Lower Respiratory Tract Infection. Pediatr Infect Dis J (2016) 0.88

Significantly skewed memory CD8+ T cell subsets in HIV-1 infected infants during the first year of life. Clin Immunol (2008) 0.87

Vaginal microbicides for reducing the risk of sexual acquisition of HIV infection in women: systematic review and meta-analysis. BMC Infect Dis (2012) 0.87

Cardiac myosin epitopes for monitoring progression of rheumatic fever. Pediatr Infect Dis J (2011) 0.84

Developing vaccinology expertise for Africa: six years and counting. Vaccine (2011) 0.84

Quinolone treatment for pediatric bacterial meningitis: a comparative study of trovafloxacin and ceftriaxone with or without vancomycin. Pediatr Infect Dis J (2002) 0.83

The African Vaccine-Preventable Diseases Network: a vaccine advocacy initiative. Pan Afr Med J (2011) 0.83

Lessons and myths in the HIV/AIDS response. Lancet (2009) 0.81

Trends in the types and quality of childhood immunisations research output from Africa 1970-2010: mapping the evidence base. BMC Health Serv Res (2014) 0.80

HIV-specific gag responses in early infancy correlate with clinical outcome and inversely with viral load. AIDS Res Hum Retroviruses (2011) 0.77

Use of systematic reviews in WHO recommendations. Lancet (2011) 0.77

The Role of Clinical Symptoms in the Diagnosis of Intrathoracic Tuberculosis in Young Children. Pediatr Infect Dis J (2015) 0.75

Knowledge, attitudes and practices on adolescent vaccination among parents, teachers and adolescents in Africa: a systematic review protocol. Syst Rev (2014) 0.75

Public stewardship of private for-profit healthcare providers in low- and middle-income countries. Cochrane Database Syst Rev (2016) 0.75

Safety of licensed vaccines in HIV-infected persons: a systematic review protocol. Syst Rev (2014) 0.75

SATVI - after 10 years closing in on a new and better vaccine to prevent tuberculosis. S Afr Med J (2012) 0.75